Promega to Showcase Oncology Research Tools and Companion Diagnostics at AACR Annual Meeting 2026

On April 16, 2026 Promega Corporation, a Madison, Wisconsin-based life science tools company, reported it will present new technologies for cell health, target engagement and oncology diagnostics at the AACR (Free AACR Whitepaper) Annual Meeting 2026 in San Diego, April 17-22. Researchers attending the conference can explore tools spanning oncology research, drug discovery and diagnostics workflows at Booth #2229 in the San Diego Convention Center.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Topics to be discussed at the conference include:

Lumit hKi-67 Immunoassay for Cell Proliferation: A plate-based assay for tracking a well-known marker of cell proliferation
TarSeer BRETSA Target Engagement System: A cellular, tracer-free, bioluminescence-resonance energy transfer (BRET)-based system that detects compound-protein interactions
Microsatellite Instability (MSI) Companion Diagnostics: Promega OncoMate MSI Dx Analysis System recently received regulatory approvals from the U.S. FDA and the NMPA in China.
Automated Nucleic Acid Extraction on KingFisher Instruments: Promega has released preconfigured protocols for implementing Maxwell HT purification chemistry on KingFisher Flex and Apex
Promega scientists will also be presenting thirteen research posters during the event, including the first reveal of the company’s red-shifted NanoPrism luciferase. Highlights include:

Two-color bioluminescence analyses pairing NanoLuc and red-shifted NanoPrism luciferases: Sunday April 19, 2:00 – 5:00 pm | Section 13, Board 6, Abstract #288
BRETSA: A BRET-based assay for ultra-sensitive measurement of target engagement through protein denaturation in live cells: Tuesday, April 21, 2:00 – 5:00 pm | Section 39, Board 27, Abstract #6427
Lumit-based profiling of degrader dynamics reveals signaling-dependent, cell context-specific sensitivity to degraders: Tuesday, April 21, 2:00 – 5:00 pm | Section 15, Board 26, Abstract #5799

(Press release, Promega, APR 16, 2026, View Source [SID1234664451])